Volume : 13, Issue : 04, April – 2026
Title:
INFLUENCE OF PHARMACIST-MEDIATED EDUCATION ON MEDICATION ADHERENCE BEHAVIOUR AND HEALTH-RELATED QUALITY OF LIFE IN ASTHMA PATIENTS: A COMPREHENSIVE REVIEW
Authors :
Daggula Varsha, Gorla Saritha, Golla Akhila, Gaddameedi Sreevani, Sai Pawan R Adepu and Chandrasekhara Rao Baru
Abstract :
Background: Asthma is a chronic inflammatory airway disease affecting over 300 million people globally, with suboptimal medication adherence being the leading contributor to poor disease control and diminished health-related quality of life (HRQoL). Pharmacist-mediated educational interventions have emerged as a promising strategy to bridge the adherence gap.
Objective: This review critically evaluates the existing literature on the influence of pharmacist-mediated patient education on medication adherence behaviour and HRQoL outcomes in asthmatic patients.
Methods: A systematic literature search was conducted across PubMed, MEDLINE, Cochrane Library, EMBASE, and Google Scholar databases using relevant MeSH terms. Twenty-eight peer-reviewed articles published between 2005 and 2024 were selected following PRISMA guidelines.
Results: Evidence from randomised controlled trials, quasi-experimental studies, and observational studies consistently demonstrated that pharmacist-led educational interventions significantly improved inhaler technique, medication adherence (measured by Morisky Medication Adherence Scale and pill count methods), asthma control test scores, and disease-specific HRQoL instruments including the Asthma Quality of Life Questionnaire (AQLQ) and the St. George’s Respiratory Questionnaire (SGRQ). Structured counselling, home visits, telephonic follow-ups, and digital platforms were identified as effective intervention modalities.
Conclusion: Pharmacist-mediated patient education represents a cost-effective, evidence-based approach to improving medication adherence and HRQoL in asthma patients. Integration of pharmacist-led counselling into multidisciplinary asthma management programmes is strongly warranted.
Keywords: Asthma, Pharmacist intervention, Patient education, Medication adherence, Health-related quality of life, Inhaler technique, Pharmaceutical care, AQLQ, MMAS
Cite This Article:
Please cite this article in press Saipawan R Adepu et al., Influence Of Pharmacist-Mediated Education On Medication Adherence Behaviour And Health-Related Quality Of Life In Asthma Patients: A Comprehensive Review., Indo Am. J. P. Sci, 2026; 13(04).
REFERENCES:
1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2023. Available at: www.ginasthma.org
2. Sabaté E (Ed.). Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
3. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783–800.
4. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147(4):832–838.
5. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907.
6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543.
7. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019. Lancet. 2020;396(10258):1204–1222.
8. Pearce N, Aït-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62(9):758–766.
9. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24.
10. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56.
11. Sanchis J, Gich I, Pedersen S; Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time? Chest. 2016;150(2):394–406.
12. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.
13. Bidad N, Barnes N, Griffiths C, Horne R. Understanding and overcoming poor adherence in adults with asthma: the role of health psychology. Prim Care Respir J. 2008;17(3):130–137.
14. Laforest L, Licaj I, Devouassoux G, et al. Overcoming barriers to medication adherence in asthma: a cross-sectional study. Eur Respir J. 2016;48(Suppl 60):PA4625.
15. Klok T, Kaptein AA, Brand PLP. Non-adherence in children and adolescents with asthma. Expert Rev Respir Med. 2015;9(3):235–248.
16. Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol. 2008;33(9):916–936.
17. Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502.
18. Garcia-Cardenas V, Sabater-Hernandez D, Kenny P, et al. Effect of a pharmacist intervention on asthma control. A clustered randomised trial. J Eval Clin Pract. 2013;19(5):911–917.
19. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;(1):CD001117.
20. Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax. 2003;58(10):851–854.
21. Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4):790–799.
22. Nahar N, Ibrahim B, Ismail S, et al. Pharmacist-led motivational interviewing to improve asthma outcomes: a randomised controlled trial. Respir Med. 2021;185:106490.
23. Rani S, Nagpal M, Bhatt M, et al. Effectiveness of pharmacist-mediated patient education on medication adherence and quality of life in Indian asthma patients. Asian J Pharm Clin Res. 2017;10(11):267–273.
24. Al-Jahdali H, Ahmed A, Al-Harbi A, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol. 2013;9(1):8.
25. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns. 2008;72(1):26–33.
26. Armour CL, Reddel HK, LeMay KS, et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomised trial. J Asthma. 2013;50(3):302–309.
27. Weng X, Gong X, Liu L, Wu F. The effect of pharmacist interventions on asthma outcomes: a meta-analysis. Curr Med Res Opin. 2019;35(6):1065–1075.
28. Kritikos V, Reddel HK, Bosnic-Anticevich SZ. Pharmacists’ perceptions of their role in asthma management and barriers to asthma care in the community setting. Int J Pharm Pract. 2010;18(4):209–216.
29. Hashmi FK, Atif N, Saleem F, et al. Digital pharmacist-led education for asthma management: a randomised controlled trial using WhatsApp messenger. J Asthma. 2022;59(8):1631–1639.
30. García-Cárdenas V, Sabater-Hernández D, de Oliveira-Filho AD, et al. Development of a follow-up model to optimise pharmacist interventions for asthma patients. Allergy. 2013;68(5):678–681.